

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 8.99969913 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.99969913 |
| 3 | motile cilium assembly (GO:0044458) | 7.98030017 |
| 4 | negative regulation of T-helper cell differentiation (GO:0045623) | 7.90316215 |
| 5 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 7.90316215 |
| 6 | skeletal muscle contraction (GO:0003009) | 7.51965158 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 7.15172176 |
| 8 | actin-mediated cell contraction (GO:0070252) | 7.15134792 |
| 9 | platelet dense granule organization (GO:0060155) | 6.99043636 |
| 10 | plasma membrane repair (GO:0001778) | 6.98890789 |
| 11 | purine-containing compound salvage (GO:0043101) | 6.86604255 |
| 12 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 6.79024504 |
| 13 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.73225762 |
| 14 | response to mercury ion (GO:0046689) | 6.65927548 |
| 15 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 6.58401693 |
| 16 | response to inactivity (GO:0014854) | 6.50248973 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.33161804 |
| 18 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 6.20064991 |
| 19 | purine nucleotide salvage (GO:0032261) | 6.18074354 |
| 20 | skeletal muscle adaptation (GO:0043501) | 6.11376281 |
| 21 | cytidine metabolic process (GO:0046087) | 6.06692491 |
| 22 | cytidine catabolic process (GO:0006216) | 6.06692491 |
| 23 | cytidine deamination (GO:0009972) | 6.06692491 |
| 24 | glycogen catabolic process (GO:0005980) | 5.77091226 |
| 25 | ubiquinone biosynthetic process (GO:0006744) | 5.72072219 |
| 26 | quinone biosynthetic process (GO:1901663) | 5.72072219 |
| 27 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 5.67991135 |
| 28 | cardiac myofibril assembly (GO:0055003) | 5.61443825 |
| 29 | IMP metabolic process (GO:0046040) | 5.60862265 |
| 30 | carnitine shuttle (GO:0006853) | 5.57663569 |
| 31 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.51134771 |
| 32 | glucan catabolic process (GO:0009251) | 5.46887269 |
| 33 | cardiac muscle contraction (GO:0060048) | 5.42360165 |
| 34 | cytokine production involved in immune response (GO:0002367) | 5.37649382 |
| 35 | actomyosin structure organization (GO:0031032) | 5.36439788 |
| 36 | actin filament-based movement (GO:0030048) | 5.32617105 |
| 37 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.27632509 |
| 38 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 5.19037857 |
| 39 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.16807901 |
| 40 | regulation of chronic inflammatory response (GO:0002676) | 5.14987839 |
| 41 | cellular polysaccharide catabolic process (GO:0044247) | 5.14362766 |
| 42 | glycogen biosynthetic process (GO:0005978) | 5.13312582 |
| 43 | glucan biosynthetic process (GO:0009250) | 5.13312582 |
| 44 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 5.11539570 |
| 45 | muscle fiber development (GO:0048747) | 5.10785435 |
| 46 | skeletal muscle tissue development (GO:0007519) | 5.05653080 |
| 47 | skeletal muscle fiber development (GO:0048741) | 5.03243448 |
| 48 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 5.02300530 |
| 49 | ubiquinone metabolic process (GO:0006743) | 4.98602592 |
| 50 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.87393832 |
| 51 | IMP biosynthetic process (GO:0006188) | 4.84182861 |
| 52 | lung morphogenesis (GO:0060425) | 4.84154997 |
| 53 | NADH metabolic process (GO:0006734) | 4.81946484 |
| 54 | regulation of actin filament-based movement (GO:1903115) | 4.80266524 |
| 55 | response to muscle activity (GO:0014850) | 4.78830122 |
| 56 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.74764771 |
| 57 | rRNA transcription (GO:0009303) | 4.71632576 |
| 58 | striated muscle adaptation (GO:0014888) | 4.69620043 |
| 59 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.69577750 |
| 60 | fatty acid transmembrane transport (GO:1902001) | 4.65425088 |
| 61 | polysaccharide catabolic process (GO:0000272) | 4.63273959 |
| 62 | positive regulation of myotube differentiation (GO:0010831) | 4.61441534 |
| 63 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.58174196 |
| 64 | cardiac muscle hypertrophy (GO:0003300) | 4.55725231 |
| 65 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.54994387 |
| 66 | myotube cell development (GO:0014904) | 4.48635898 |
| 67 | axonemal dynein complex assembly (GO:0070286) | 4.47599487 |
| 68 | negative regulation of acute inflammatory response (GO:0002674) | 4.41314072 |
| 69 | muscle cell cellular homeostasis (GO:0046716) | 4.40629375 |
| 70 | striated muscle hypertrophy (GO:0014897) | 4.34807522 |
| 71 | fructose metabolic process (GO:0006000) | 4.33494940 |
| 72 | regulation of proton transport (GO:0010155) | 4.30902099 |
| 73 | T cell lineage commitment (GO:0002360) | 4.28960922 |
| 74 | glycogen metabolic process (GO:0005977) | 4.13364996 |
| 75 | 2-oxoglutarate metabolic process (GO:0006103) | 4.13215752 |
| 76 | regulation of interleukin-13 production (GO:0032656) | 4.12053748 |
| 77 | muscle organ development (GO:0007517) | 4.11567944 |
| 78 | muscle structure development (GO:0061061) | 4.11445799 |
| 79 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.11058597 |
| 80 | cortical actin cytoskeleton organization (GO:0030866) | 4.08714715 |
| 81 | striated muscle contraction (GO:0006941) | 4.06973757 |
| 82 | cellular glucan metabolic process (GO:0006073) | 4.06529181 |
| 83 | glucan metabolic process (GO:0044042) | 4.06529181 |
| 84 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.05182296 |
| 85 | muscle cell fate commitment (GO:0042693) | 4.01941633 |
| 86 | sphingomyelin metabolic process (GO:0006684) | 3.99647070 |
| 87 | positive regulation of filopodium assembly (GO:0051491) | 3.98421147 |
| 88 | carnitine transmembrane transport (GO:1902603) | 3.96915922 |
| 89 | mRNA cleavage (GO:0006379) | 3.96802432 |
| 90 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.96306575 |
| 91 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.93971849 |
| 92 | muscle hypertrophy (GO:0014896) | 3.91050188 |
| 93 | striated muscle cell development (GO:0055002) | 3.89489193 |
| 94 | regulation of striated muscle contraction (GO:0006942) | 3.89032522 |
| 95 | regulation of chemokine biosynthetic process (GO:0045073) | 3.88358255 |
| 96 | defense response to protozoan (GO:0042832) | 3.87028213 |
| 97 | creatine metabolic process (GO:0006600) | 3.86832622 |
| 98 | gluconeogenesis (GO:0006094) | 3.84374352 |
| 99 | muscle tissue morphogenesis (GO:0060415) | 3.81587867 |
| 100 | muscle adaptation (GO:0043500) | 3.81577819 |
| 101 | myoblast fusion (GO:0007520) | 3.77013259 |
| 102 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.76957786 |
| 103 | muscle contraction (GO:0006936) | 3.75556391 |
| 104 | sarcomere organization (GO:0045214) | 3.72793245 |
| 105 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.72504460 |
| 106 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.72504460 |
| 107 | adult heart development (GO:0007512) | 3.66817508 |
| 108 | amino-acid betaine transport (GO:0015838) | 3.61363131 |
| 109 | carnitine transport (GO:0015879) | 3.61363131 |
| 110 | cortical cytoskeleton organization (GO:0030865) | 3.60709144 |
| 111 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.59228550 |
| 112 | skeletal muscle tissue regeneration (GO:0043403) | 3.58337499 |
| 113 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.58012074 |
| 114 | negative regulation of muscle contraction (GO:0045932) | 3.57902685 |
| 115 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.56916765 |
| 116 | regulation of myoblast differentiation (GO:0045661) | 3.56702263 |
| 117 | secretory granule organization (GO:0033363) | 3.53203707 |
| 118 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.53089193 |
| 119 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.53089193 |
| 120 | production of molecular mediator of immune response (GO:0002440) | 3.52997274 |
| 121 | striated muscle atrophy (GO:0014891) | 3.52702503 |
| 122 | positive regulation of DNA recombination (GO:0045911) | 3.51927600 |
| 123 | neuronal action potential propagation (GO:0019227) | 3.50642906 |
| 124 | quinone metabolic process (GO:1901661) | 3.49179850 |
| 125 | negative regulation of monooxygenase activity (GO:0032769) | 3.46173751 |
| 126 | positive regulation of myoblast differentiation (GO:0045663) | 3.45508422 |
| 127 | hexose biosynthetic process (GO:0019319) | 3.44611164 |
| 128 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.42889027 |
| 129 | myotube differentiation (GO:0014902) | 3.41698777 |
| 130 | tricarboxylic acid cycle (GO:0006099) | 3.41696900 |
| 131 | nucleotide salvage (GO:0043173) | 3.40386619 |
| 132 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.40241787 |
| 133 | muscle hypertrophy in response to stress (GO:0003299) | 3.40241787 |
| 134 | cardiac muscle adaptation (GO:0014887) | 3.40241787 |
| 135 | cardiac muscle cell development (GO:0055013) | 3.39359272 |
| 136 | * response to activity (GO:0014823) | 3.38998798 |
| 137 | striated muscle tissue development (GO:0014706) | 3.38872511 |
| 138 | myofibril assembly (GO:0030239) | 3.38736742 |
| 139 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.36639014 |
| 140 | muscle cell development (GO:0055001) | 3.36410888 |
| 141 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.36110193 |
| 142 | muscle atrophy (GO:0014889) | 3.33854038 |
| 143 | purine nucleobase metabolic process (GO:0006144) | 3.33794079 |
| 144 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.33784772 |
| 145 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.33019456 |
| 146 | T-helper cell differentiation (GO:0042093) | 3.33019456 |
| 147 | cellular carbohydrate catabolic process (GO:0044275) | 3.28782885 |
| 148 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.28606979 |
| 149 | activation of protein kinase A activity (GO:0034199) | 3.27928370 |
| 150 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.25558426 |
| 151 | muscle system process (GO:0003012) | 3.25489470 |
| 152 | regulation of myotube differentiation (GO:0010830) | 3.25109679 |
| 153 | response to protozoan (GO:0001562) | 3.25082712 |
| 154 | regulation of relaxation of muscle (GO:1901077) | 3.23903430 |
| 155 | regulation of sequestering of triglyceride (GO:0010889) | 3.23285521 |
| 156 | regulation of cell communication by electrical coupling (GO:0010649) | 3.22552607 |
| 157 | regulation of the force of heart contraction (GO:0002026) | 3.21670390 |
| 158 | innate immune response in mucosa (GO:0002227) | 3.20338141 |
| 159 | regulation of membrane lipid distribution (GO:0097035) | 3.18460741 |
| 160 | positive regulation of cation channel activity (GO:2001259) | 3.17661009 |
| 161 | neuromuscular synaptic transmission (GO:0007274) | 3.17584502 |
| 162 | positive regulation of activated T cell proliferation (GO:0042104) | 3.15865796 |
| 163 | positive regulation of glucose import (GO:0046326) | 3.13933163 |
| 164 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.10627151 |
| 165 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.08517853 |
| 166 | Peyers patch development (GO:0048541) | 3.08517853 |
| 167 | positive regulation of isotype switching (GO:0045830) | 2.98352817 |
| 168 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.97699381 |
| 169 | phospholipid scrambling (GO:0017121) | 11.2617276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.14176028 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 5.16460846 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.57526950 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.48808895 |
| 5 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 3.17299592 |
| 6 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.16063219 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.95003288 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.72010396 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.70593883 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.63526870 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.56637873 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.47120706 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.46355057 |
| 14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.40327083 |
| 15 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 2.39314980 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.34361170 |
| 17 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.32242087 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.31823635 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.30464479 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20100927 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.06861748 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.00475195 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.97694397 |
| 24 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.95665830 |
| 25 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.93952705 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.91043885 |
| 27 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.88282267 |
| 28 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.82302014 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.81782088 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77507075 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75767510 |
| 32 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.71186965 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68289299 |
| 34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.67225589 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.63395627 |
| 36 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.62610105 |
| 37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.61525758 |
| 38 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.52479725 |
| 39 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.44743755 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43302978 |
| 41 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43197934 |
| 42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.42763698 |
| 43 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.42074541 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41345060 |
| 45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40898112 |
| 46 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.40135677 |
| 47 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.40108869 |
| 48 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.40010194 |
| 49 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.40010194 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35200340 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34050848 |
| 52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33216241 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31877179 |
| 54 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30645157 |
| 55 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.27499488 |
| 56 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.26706574 |
| 57 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25935412 |
| 58 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.25440078 |
| 59 | P300_27268052_Chip-Seq_Bcells_Human | 1.24908405 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23158144 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22148891 |
| 62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21110542 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19664986 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19506941 |
| 65 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.18700372 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18692191 |
| 67 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18641541 |
| 68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17540208 |
| 69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17364337 |
| 70 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.17346149 |
| 71 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.17138027 |
| 72 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16675033 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.14790805 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13997465 |
| 75 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.13781861 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12728610 |
| 77 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12398191 |
| 78 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11628945 |
| 79 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.10670906 |
| 80 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.10163592 |
| 81 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09695637 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09687816 |
| 83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09444872 |
| 84 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.08803287 |
| 85 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.07950627 |
| 86 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07828521 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06606149 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06327295 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05908293 |
| 90 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.05841314 |
| 91 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05026861 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04739709 |
| 93 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03163672 |
| 94 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.02720709 |
| 95 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.02691099 |
| 96 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01716668 |
| 97 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01711954 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.00878117 |
| 99 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00772071 |
| 100 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00167326 |
| 101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00148200 |
| 102 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99728148 |
| 103 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99711474 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99632985 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99473653 |
| 106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98687275 |
| 107 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98286771 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98257165 |
| 109 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97822516 |
| 110 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.97772271 |
| 111 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96876501 |
| 112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96815506 |
| 113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96248825 |
| 114 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96127350 |
| 115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95428652 |
| 116 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94937730 |
| 117 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94879966 |
| 118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94761334 |
| 119 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.93346860 |
| 120 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93218361 |
| 121 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.91593717 |
| 122 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90719488 |
| 123 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90577909 |
| 124 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90503992 |
| 125 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.89741520 |
| 126 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.89184718 |
| 127 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89056212 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87655748 |
| 129 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.87567047 |
| 130 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87473335 |
| 131 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.87265582 |
| 132 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87162561 |
| 133 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86994802 |
| 134 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86601832 |
| 135 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86506817 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86418681 |
| 137 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85841234 |
| 138 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85756651 |
| 139 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.85551833 |
| 140 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.85334158 |
| 141 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.84518454 |
| 142 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83578683 |
| 143 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82819671 |
| 144 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.82319066 |
| 145 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.81278113 |
| 146 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81160508 |
| 147 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80077202 |
| 148 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.79151550 |
| 149 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78792627 |
| 150 | MAF_26560356_Chip-Seq_TH1_Human | 0.76188608 |
| 151 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75957377 |
| 152 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.74889109 |
| 153 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.74870093 |
| 154 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.74656251 |
| 155 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.74576112 |
| 156 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.73607942 |
| 157 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.71055143 |
| 158 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.70634112 |
| 159 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.69914265 |
| 160 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69322946 |
| 161 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.68282375 |
| 162 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67386819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.55593282 |
| 2 | MP0000749_muscle_degeneration | 5.60337599 |
| 3 | MP0001348_abnormal_lacrimal_gland | 5.13711174 |
| 4 | MP0003646_muscle_fatigue | 4.97913669 |
| 5 | MP0000751_myopathy | 4.80644201 |
| 6 | MP0000747_muscle_weakness | 3.97421419 |
| 7 | MP0005451_abnormal_body_composition | 3.73931519 |
| 8 | MP0002106_abnormal_muscle_physiology | 3.57499307 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.08057165 |
| 10 | * MP0000759_abnormal_skeletal_muscle | 3.03314484 |
| 11 | MP0004036_abnormal_muscle_relaxation | 3.02019768 |
| 12 | MP0004510_myositis | 2.96507166 |
| 13 | MP0005310_abnormal_salivary_gland | 2.95480886 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.93074745 |
| 15 | MP0005369_muscle_phenotype | 2.91806587 |
| 16 | MP0001873_stomach_inflammation | 2.76302824 |
| 17 | MP0003950_abnormal_plasma_membrane | 2.73322453 |
| 18 | MP0002269_muscular_atrophy | 2.72310864 |
| 19 | MP0005330_cardiomyopathy | 2.57712835 |
| 20 | MP0000750_abnormal_muscle_regeneration | 2.36295615 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 2.31029805 |
| 22 | MP0003221_abnormal_cardiomyocyte_apopto | 2.25199762 |
| 23 | * MP0005620_abnormal_muscle_contractility | 2.17851825 |
| 24 | MP0001853_heart_inflammation | 2.13472748 |
| 25 | MP0004130_abnormal_muscle_cell | 2.12039415 |
| 26 | MP0006082_CNS_inflammation | 2.05405397 |
| 27 | MP0000733_abnormal_muscle_development | 2.01077561 |
| 28 | MP0004233_abnormal_muscle_weight | 1.74696455 |
| 29 | * MP0002332_abnormal_exercise_endurance | 1.69660888 |
| 30 | MP0004484_altered_response_of | 1.56641831 |
| 31 | MP0000013_abnormal_adipose_tissue | 1.48744073 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.45222599 |
| 33 | MP0009697_abnormal_copulation | 1.42953715 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.38499729 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.34837640 |
| 36 | MP0002108_abnormal_muscle_morphology | 1.31882399 |
| 37 | MP0005166_decreased_susceptibility_to | 1.24620212 |
| 38 | MP0002254_reproductive_system_inflammat | 1.21512080 |
| 39 | MP0004270_analgesia | 1.20459840 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.18620796 |
| 41 | * MP0005266_abnormal_metabolism | 1.18374095 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.17101165 |
| 43 | MP0006292_abnormal_olfactory_placode | 1.15098243 |
| 44 | MP0005501_abnormal_skin_physiology | 1.10942397 |
| 45 | MP0002822_catalepsy | 1.03746540 |
| 46 | MP0005083_abnormal_biliary_tract | 1.03522991 |
| 47 | MP0002971_abnormal_brown_adipose | 0.99974793 |
| 48 | MP0004215_abnormal_myocardial_fiber | 0.94639929 |
| 49 | MP0005666_abnormal_adipose_tissue | 0.93866796 |
| 50 | MP0001661_extended_life_span | 0.92213348 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 0.90511441 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 0.86076656 |
| 53 | MP0002972_abnormal_cardiac_muscle | 0.85047829 |
| 54 | MP0005165_increased_susceptibility_to | 0.83826536 |
| 55 | MP0001835_abnormal_antigen_presentation | 0.83776851 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 0.83740471 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 0.81801102 |
| 58 | MP0003828_pulmonary_edema | 0.81328691 |
| 59 | MP0000343_altered_response_to | 0.80539550 |
| 60 | MP0005385_cardiovascular_system_phenoty | 0.78513911 |
| 61 | MP0001544_abnormal_cardiovascular_syste | 0.78513911 |
| 62 | MP0000003_abnormal_adipose_tissue | 0.78495816 |
| 63 | MP0003045_fibrosis | 0.77346275 |
| 64 | MP0008872_abnormal_physiological_respon | 0.76784367 |
| 65 | MP0000685_abnormal_immune_system | 0.71513179 |
| 66 | MP0008775_abnormal_heart_ventricle | 0.71182413 |
| 67 | MP0001177_atelectasis | 0.69397735 |
| 68 | MP0010329_abnormal_lipoprotein_level | 0.68886652 |
| 69 | MP0003879_abnormal_hair_cell | 0.68728492 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66462042 |
| 71 | MP0004147_increased_porphyrin_level | 0.65984596 |
| 72 | MP0001851_eye_inflammation | 0.63472904 |
| 73 | MP0006138_congestive_heart_failure | 0.62510546 |
| 74 | MP0004134_abnormal_chest_morphology | 0.62347486 |
| 75 | MP0002970_abnormal_white_adipose | 0.60553149 |
| 76 | MP0003137_abnormal_impulse_conducting | 0.60271721 |
| 77 | MP0000372_irregular_coat_pigmentation | 0.59822567 |
| 78 | MP0004085_abnormal_heartbeat | 0.58879141 |
| 79 | * MP0005376_homeostasis/metabolism_phenot | 0.57162667 |
| 80 | MP0005535_abnormal_body_temperature | 0.56788715 |
| 81 | MP0002127_abnormal_cardiovascular_syste | 0.56746822 |
| 82 | MP0005275_abnormal_skin_tensile | 0.55554707 |
| 83 | MP0002234_abnormal_pharynx_morphology | 0.55311195 |
| 84 | MP0001186_pigmentation_phenotype | 0.54713390 |
| 85 | MP0001849_ear_inflammation | 0.54266016 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 0.53432154 |
| 87 | MP0005670_abnormal_white_adipose | 0.52906279 |
| 88 | MP0005464_abnormal_platelet_physiology | 0.51246312 |
| 89 | MP0003786_premature_aging | 0.50819310 |
| 90 | MP0000762_abnormal_tongue_morphology | 0.49936639 |
| 91 | MP0002075_abnormal_coat/hair_pigmentati | 0.49331831 |
| 92 | MP0004957_abnormal_blastocyst_morpholog | 0.49294144 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.49142456 |
| 94 | MP0001879_abnormal_lymphatic_vessel | 0.49048858 |
| 95 | MP0008438_abnormal_cutaneous_collagen | 0.48036826 |
| 96 | MP0003252_abnormal_bile_duct | 0.47955271 |
| 97 | MP0003567_abnormal_fetal_cardiomyocyte | 0.47664402 |
| 98 | MP0002796_impaired_skin_barrier | 0.47264827 |
| 99 | MP0003948_abnormal_gas_homeostasis | 0.46408834 |
| 100 | MP0000371_diluted_coat_color | 0.46382402 |
| 101 | MP0004947_skin_inflammation | 0.45484220 |
| 102 | MP0004043_abnormal_pH_regulation | 0.44915444 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.43746612 |
| 104 | MP0003705_abnormal_hypodermis_morpholog | 0.41168935 |
| 105 | MP0001346_abnormal_lacrimal_gland | 0.40719947 |
| 106 | MP0005375_adipose_tissue_phenotype | 0.40512173 |
| 107 | MP0001663_abnormal_digestive_system | 0.40419358 |
| 108 | MP0004142_abnormal_muscle_tone | 0.39627389 |
| 109 | MP0009672_abnormal_birth_weight | 0.39605772 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.39547171 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.39488551 |
| 112 | MP0002095_abnormal_skin_pigmentation | 0.39434846 |
| 113 | MP0005452_abnormal_adipose_tissue | 0.39321640 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 0.38483947 |
| 115 | MP0008569_lethality_at_weaning | 0.38223926 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.37364362 |
| 117 | MP0002128_abnormal_blood_circulation | 0.36266955 |
| 118 | MP0000266_abnormal_heart_morphology | 0.36013875 |
| 119 | MP0005448_abnormal_energy_balance | 0.34246507 |
| 120 | MP0002114_abnormal_axial_skeleton | 0.34190938 |
| 121 | MP0002638_abnormal_pupillary_reflex | 0.29829169 |
| 122 | MP0005334_abnormal_fat_pad | 0.29824463 |
| 123 | MP0010030_abnormal_orbit_morphology | 0.29394345 |
| 124 | MP0002896_abnormal_bone_mineralization | 0.28497365 |
| 125 | MP0002734_abnormal_mechanical_nocicepti | 0.27162662 |
| 126 | MP0009250_abnormal_appendicular_skeleto | 0.24276728 |
| 127 | MP0001943_abnormal_respiration | 0.24192001 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.24180326 |
| 129 | MP0004858_abnormal_nervous_system | 0.22014610 |
| 130 | MP0002249_abnormal_larynx_morphology | 0.19948011 |
| 131 | MP0005423_abnormal_somatic_nervous | 0.18925308 |
| 132 | MP0002066_abnormal_motor_capabilities/c | 0.18615883 |
| 133 | MP0005332_abnormal_amino_acid | 0.18152440 |
| 134 | MP0008874_decreased_physiological_sensi | 0.16922497 |
| 135 | MP0003959_abnormal_lean_body | 0.15288650 |
| 136 | MP0009115_abnormal_fat_cell | 0.13811048 |
| 137 | MP0006276_abnormal_autonomic_nervous | 0.13615297 |
| 138 | MP0005187_abnormal_penis_morphology | 0.13114615 |
| 139 | MP0002067_abnormal_sensory_capabilities | 0.11560150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.75448630 |
| 2 | Nemaline bodies (HP:0003798) | 9.51252144 |
| 3 | Type 1 muscle fiber predominance (HP:0003803) | 7.84546836 |
| 4 | Distal arthrogryposis (HP:0005684) | 6.60952647 |
| 5 | Exercise-induced myalgia (HP:0003738) | 6.50475902 |
| 6 | Progressive muscle weakness (HP:0003323) | 6.25082728 |
| 7 | Myopathic facies (HP:0002058) | 6.13905361 |
| 8 | Myoglobinuria (HP:0002913) | 5.85949485 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 5.75853940 |
| 10 | Absent/shortened dynein arms (HP:0200106) | 5.65747777 |
| 11 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.65747777 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.11200516 |
| 13 | Round ear (HP:0100830) | 5.07126866 |
| 14 | Ulnar deviation of the wrist (HP:0003049) | 5.01225317 |
| 15 | Nasal polyposis (HP:0100582) | 4.68567333 |
| 16 | Calf muscle hypertrophy (HP:0008981) | 4.62473447 |
| 17 | Muscle fiber splitting (HP:0003555) | 4.55264798 |
| 18 | Difficulty running (HP:0009046) | 4.21289465 |
| 19 | Abnormality of the nasal mucosa (HP:0000433) | 4.21219694 |
| 20 | Calcaneovalgus deformity (HP:0001848) | 4.19218577 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 3.98643159 |
| 22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.79972493 |
| 23 | Rimmed vacuoles (HP:0003805) | 3.78499304 |
| 24 | Scanning speech (HP:0002168) | 3.77629988 |
| 25 | EMG: myopathic abnormalities (HP:0003458) | 3.74668104 |
| 26 | Deformed tarsal bones (HP:0008119) | 3.74244295 |
| 27 | Muscle stiffness (HP:0003552) | 3.73543781 |
| 28 | Increased connective tissue (HP:0009025) | 3.72133404 |
| 29 | Absent phalangeal crease (HP:0006109) | 3.63438557 |
| 30 | Asymmetric septal hypertrophy (HP:0001670) | 3.50445876 |
| 31 | Neck muscle weakness (HP:0000467) | 3.46531173 |
| 32 | Ragged-red muscle fibers (HP:0003200) | 3.34816796 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 3.28657014 |
| 34 | Myotonia (HP:0002486) | 3.25119827 |
| 35 | Abnormality of the calf musculature (HP:0001430) | 3.21875637 |
| 36 | Frequent falls (HP:0002359) | 3.15255447 |
| 37 | Areflexia of lower limbs (HP:0002522) | 3.14730398 |
| 38 | Rhabdomyolysis (HP:0003201) | 3.13963133 |
| 39 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.03731373 |
| 40 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.03731373 |
| 41 | Abnormal finger flexion creases (HP:0006143) | 3.01619840 |
| 42 | Abnormal ciliary motility (HP:0012262) | 2.90837697 |
| 43 | Atrioventricular block (HP:0001678) | 2.88502970 |
| 44 | Nonprogressive disorder (HP:0003680) | 2.80493295 |
| 45 | Fetal akinesia sequence (HP:0001989) | 2.79862396 |
| 46 | Fatigable weakness (HP:0003473) | 2.65273348 |
| 47 | Abnormality of the neuromuscular junction (HP:0003398) | 2.65273348 |
| 48 | Postural instability (HP:0002172) | 2.60865043 |
| 49 | Difficulty climbing stairs (HP:0003551) | 2.59088779 |
| 50 | EMG: neuropathic changes (HP:0003445) | 2.54218245 |
| 51 | Abnormality of the calcaneus (HP:0008364) | 2.44543202 |
| 52 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.42400524 |
| 53 | Malignant hyperthermia (HP:0002047) | 2.42205699 |
| 54 | Limb-girdle muscle atrophy (HP:0003797) | 2.41138770 |
| 55 | Heart block (HP:0012722) | 2.40973926 |
| 56 | Facial diplegia (HP:0001349) | 2.39674602 |
| 57 | Weak cry (HP:0001612) | 2.38088060 |
| 58 | Dilated cardiomyopathy (HP:0001644) | 2.33163351 |
| 59 | Abnormal atrioventricular conduction (HP:0005150) | 2.29140379 |
| 60 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.23052366 |
| 61 | Subaortic stenosis (HP:0001682) | 2.23052366 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 2.21993776 |
| 63 | Slender build (HP:0001533) | 2.18731443 |
| 64 | Spinal rigidity (HP:0003306) | 2.16053174 |
| 65 | Type 2 muscle fiber atrophy (HP:0003554) | 2.15229810 |
| 66 | Bulbar palsy (HP:0001283) | 2.14968947 |
| 67 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.13859811 |
| 68 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.13859811 |
| 69 | Pelvic girdle muscle weakness (HP:0003749) | 2.12180066 |
| 70 | Hyperkalemia (HP:0002153) | 2.11235929 |
| 71 | Shoulder girdle muscle weakness (HP:0003547) | 2.09339157 |
| 72 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.07087286 |
| 73 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06459879 |
| 74 | Hip contracture (HP:0003273) | 2.05686536 |
| 75 | Lipoatrophy (HP:0100578) | 2.00254611 |
| 76 | Muscle fiber inclusion bodies (HP:0100299) | 10.6968075 |
| 77 | Muscle fiber atrophy (HP:0100295) | 1.98900115 |
| 78 | Abnormality of the foot musculature (HP:0001436) | 1.98829594 |
| 79 | Bundle branch block (HP:0011710) | 1.98385504 |
| 80 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.95850141 |
| 81 | Gowers sign (HP:0003391) | 1.95248779 |
| 82 | Lower limb amyotrophy (HP:0007210) | 1.94577917 |
| 83 | Scapular winging (HP:0003691) | 1.91133614 |
| 84 | Metatarsus adductus (HP:0001840) | 1.87632337 |
| 85 | Proximal amyotrophy (HP:0007126) | 1.83978932 |
| 86 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.83938763 |
| 87 | Generalized muscle weakness (HP:0003324) | 1.83473549 |
| 88 | Foot dorsiflexor weakness (HP:0009027) | 1.82488187 |
| 89 | Long clavicles (HP:0000890) | 1.81364948 |
| 90 | Popliteal pterygium (HP:0009756) | 1.81179522 |
| 91 | Waddling gait (HP:0002515) | 1.79627446 |
| 92 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.72933076 |
| 93 | Sudden death (HP:0001699) | 1.72319384 |
| 94 | Distal lower limb amyotrophy (HP:0008944) | 1.70155743 |
| 95 | Hypoplastic ischia (HP:0003175) | 1.69751292 |
| 96 | Muscular dystrophy (HP:0003560) | 1.68119812 |
| 97 | Paralysis (HP:0003470) | 1.66521815 |
| 98 | Exercise intolerance (HP:0003546) | 1.65662977 |
| 99 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.62862623 |
| 100 | Respiratory distress (HP:0002098) | 1.62432866 |
| 101 | Ulnar deviation of finger (HP:0009465) | 1.60347596 |
| 102 | Congenital hip dislocation (HP:0001374) | 1.58304490 |
| 103 | Easy fatigability (HP:0003388) | 1.56953018 |
| 104 | Limited hip movement (HP:0008800) | 1.56925485 |
| 105 | Spastic paraparesis (HP:0002313) | 1.55214858 |
| 106 | Progressive external ophthalmoplegia (HP:0000590) | 1.50401028 |
| 107 | Ventricular arrhythmia (HP:0004308) | 1.50373725 |
| 108 | Increased IgE level (HP:0003212) | 1.48968005 |
| 109 | Abnormal EKG (HP:0003115) | 1.47308014 |
| 110 | Limb-girdle muscle weakness (HP:0003325) | 1.44553167 |
| 111 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.43156894 |
| 112 | Ventricular tachycardia (HP:0004756) | 1.42360461 |
| 113 | Achilles tendon contracture (HP:0001771) | 1.41467318 |
| 114 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.40055677 |
| 115 | Increased intramyocellular lipid droplets (HP:0012240) | 1.38871395 |
| 116 | Breech presentation (HP:0001623) | 1.33859503 |
| 117 | Amniotic constriction ring (HP:0009775) | 1.33047216 |
| 118 | Abnormality of placental membranes (HP:0011409) | 1.33047216 |
| 119 | Oligomenorrhea (HP:0000876) | 1.30722162 |
| 120 | Increased muscle lipid content (HP:0009058) | 1.29882424 |
| 121 | Adducted thumb (HP:0001181) | 1.28774783 |
| 122 | Steppage gait (HP:0003376) | 1.28341832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.17231328 |
| 2 | PINK1 | 4.05282771 |
| 3 | MUSK | 3.96921604 |
| 4 | PIK3CG | 3.71707414 |
| 5 | PHKG2 | 2.99320134 |
| 6 | PHKG1 | 2.99320134 |
| 7 | NME1 | 2.82437467 |
| 8 | MAP3K12 | 2.39684992 |
| 9 | MAP2K3 | 2.29146761 |
| 10 | OBSCN | 10.1133768 |
| 11 | TGFBR2 | 1.74177919 |
| 12 | CDK9 | 1.64279539 |
| 13 | MAP3K7 | 1.63005673 |
| 14 | NEK1 | 1.61074266 |
| 15 | BCKDK | 1.57603914 |
| 16 | MAP2K6 | 1.50639887 |
| 17 | DMPK | 1.44509624 |
| 18 | PDK3 | 1.43163418 |
| 19 | PDK4 | 1.43163418 |
| 20 | CDK19 | 1.35922924 |
| 21 | EEF2K | 1.20513874 |
| 22 | TRPM7 | 1.17716663 |
| 23 | EIF2AK1 | 1.14369240 |
| 24 | ROCK1 | 1.08453598 |
| 25 | MAPK12 | 1.04922802 |
| 26 | ERN1 | 1.00515147 |
| 27 | TIE1 | 0.99768626 |
| 28 | MKNK2 | 0.98536817 |
| 29 | RPS6KA5 | 0.97949938 |
| 30 | CCNB1 | 0.95779046 |
| 31 | MYLK | 0.93309777 |
| 32 | MAP2K4 | 0.91594345 |
| 33 | MARK1 | 0.91198460 |
| 34 | MAP3K11 | 0.88371982 |
| 35 | STK16 | 0.87883629 |
| 36 | CHUK | 0.87155893 |
| 37 | DYRK3 | 0.85165332 |
| 38 | PDK2 | 0.82835222 |
| 39 | MAP3K13 | 0.82628285 |
| 40 | LIMK1 | 0.80935761 |
| 41 | PRKD2 | 0.80837499 |
| 42 | MKNK1 | 0.76137092 |
| 43 | TRIB3 | 0.71934159 |
| 44 | AKT2 | 0.64212883 |
| 45 | RIPK1 | 0.63933026 |
| 46 | TGFBR1 | 0.63912459 |
| 47 | PRKAA2 | 0.60394382 |
| 48 | PIK3CA | 0.60096411 |
| 49 | PAK4 | 0.58893640 |
| 50 | MAPKAPK3 | 0.58887786 |
| 51 | EIF2AK3 | 0.58792624 |
| 52 | ILK | 0.57232880 |
| 53 | KSR2 | 0.56042148 |
| 54 | RPS6KB2 | 0.51924021 |
| 55 | HIPK2 | 0.51687640 |
| 56 | MAP3K3 | 0.47267403 |
| 57 | NME2 | 0.47096210 |
| 58 | DYRK1B | 0.46964421 |
| 59 | PKN1 | 0.46787597 |
| 60 | MATK | 0.46783420 |
| 61 | PRPF4B | 0.46168286 |
| 62 | BMX | 0.45444734 |
| 63 | CAMK2G | 0.44129873 |
| 64 | MAP2K1 | 0.43312511 |
| 65 | CAMK1 | 0.42528160 |
| 66 | MAP4K1 | 0.41960919 |
| 67 | PKN2 | 0.40769579 |
| 68 | CAMK2D | 0.40188952 |
| 69 | RPS6KA1 | 0.38748804 |
| 70 | NEK9 | 0.38401532 |
| 71 | MAPK11 | 0.36896864 |
| 72 | TAOK2 | 0.36872926 |
| 73 | CAMK2B | 0.35742922 |
| 74 | MAP3K6 | 0.35421510 |
| 75 | PRKCH | 0.34654910 |
| 76 | MARK2 | 0.32828959 |
| 77 | SIK1 | 0.30092420 |
| 78 | SGK3 | 0.28847760 |
| 79 | ZAP70 | 0.27786719 |
| 80 | MAPK13 | 0.27596102 |
| 81 | RPS6KB1 | 0.27367852 |
| 82 | TEC | 0.26749812 |
| 83 | MAP3K10 | 0.26080507 |
| 84 | PIM1 | 0.24942442 |
| 85 | PDPK1 | 0.24906169 |
| 86 | CAMK4 | 0.24612801 |
| 87 | MAPK10 | 0.24249252 |
| 88 | CDK6 | 0.23988404 |
| 89 | EPHB1 | 0.23538593 |
| 90 | LATS2 | 0.23239597 |
| 91 | MAPK8 | 0.22861894 |
| 92 | RPS6KA3 | 0.22752267 |
| 93 | NEK6 | 0.22426087 |
| 94 | TNK2 | 0.21436196 |
| 95 | DAPK1 | 0.21342129 |
| 96 | MAPK4 | 0.20828607 |
| 97 | MAPK9 | 0.19899632 |
| 98 | DAPK3 | 0.19876493 |
| 99 | PDK1 | 0.19634057 |
| 100 | LRRK2 | 0.19446076 |
| 101 | * PRKACA | 0.18902276 |
| 102 | ARAF | 0.18862118 |
| 103 | TXK | 0.18672815 |
| 104 | TAOK1 | 0.18390481 |
| 105 | MARK3 | 0.18065937 |
| 106 | PRKACG | 0.17681493 |
| 107 | SGK2 | 0.17650189 |
| 108 | PRKD1 | 0.16824763 |
| 109 | CDK5 | 0.16083757 |
| 110 | ERBB3 | 0.15719812 |
| 111 | AURKB | 0.15514195 |
| 112 | ICK | 0.15461708 |
| 113 | RPS6KC1 | 0.15397987 |
| 114 | RPS6KL1 | 0.15397987 |
| 115 | TYK2 | 0.15062017 |
| 116 | PRKAA1 | 0.14910804 |
| 117 | DDR2 | 0.14831829 |
| 118 | IRAK1 | 0.14444722 |
| 119 | DAPK2 | 0.14175629 |
| 120 | STK11 | 0.13784774 |
| 121 | MOS | 0.13582667 |
| 122 | SGK223 | 0.13142227 |
| 123 | SGK494 | 0.13142227 |
| 124 | MTOR | 0.12863134 |
| 125 | ABL1 | 0.12599130 |
| 126 | FGFR3 | 0.12486741 |
| 127 | RAF1 | 0.11736174 |
| 128 | CSF1R | 0.11707757 |
| 129 | EPHA3 | 0.11705133 |
| 130 | MAPK7 | 0.11546383 |
| 131 | MAP3K8 | 0.11342524 |
| 132 | TBK1 | 0.11040072 |
| 133 | RPS6KA6 | 0.10675794 |
| 134 | MAP3K1 | 0.10494951 |
| 135 | PRKACB | 0.10257061 |
| 136 | KSR1 | 0.09724648 |
| 137 | PRKG1 | 0.09116240 |
| 138 | CDC42BPA | 0.08114612 |
| 139 | CAMK2A | 0.07672773 |
| 140 | SGK1 | 0.07578916 |
| 141 | NLK | 0.07269130 |
| 142 | IKBKB | 0.07154562 |
| 143 | PTK2B | 0.07041468 |
| 144 | JAK2 | 0.05923956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 5.63092994 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.48865321 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.40979156 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.40028625 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.37054735 |
| 6 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.86460987 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.65078256 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.60793135 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.31115989 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.29356525 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.26395407 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.10722544 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.93962534 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.83907001 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.78338678 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74687253 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.74665505 |
| 18 | ABC transporters_Homo sapiens_hsa02010 | 1.71023940 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70462808 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.67852512 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.63725134 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.60600654 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.59986104 |
| 24 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.55115684 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.47825175 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42074838 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.38455760 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.35634199 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.34130407 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.29851260 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.29376118 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29306857 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.28983483 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.28069572 |
| 35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.26631351 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22383538 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20856532 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17322869 |
| 39 | Insulin resistance_Homo sapiens_hsa04931 | 1.14707853 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07770991 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 1.05246289 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00642822 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99542275 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99020683 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98709472 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 0.90894718 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81365134 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77667053 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76882223 |
| 50 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76461058 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74509886 |
| 52 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.71725752 |
| 53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67638714 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 0.66515262 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64885726 |
| 56 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62761568 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61016488 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.60653551 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59743987 |
| 60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58754792 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56930107 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54770123 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53948856 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53685651 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52562983 |
| 66 | Tight junction_Homo sapiens_hsa04530 | 0.51336584 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.49447135 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48763157 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48013548 |
| 70 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47656928 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46266988 |
| 72 | DNA replication_Homo sapiens_hsa03030 | 0.45577009 |
| 73 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.45097505 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.45027557 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44449890 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43997221 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43967307 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.43879303 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43781624 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43385727 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39838096 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38767787 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.37937143 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37367561 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35950693 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34444405 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34293811 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.33658119 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32927601 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32895064 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.32869135 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32291294 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30293122 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.29849318 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29676852 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.28237538 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.27994590 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.27735334 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.27718230 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26392499 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26174334 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25146987 |
| 103 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.25134676 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.25097245 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.24666162 |
| 106 | Measles_Homo sapiens_hsa05162 | 0.24625687 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23957930 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23252691 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22722160 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22603853 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22499141 |
| 112 | Peroxisome_Homo sapiens_hsa04146 | 0.22244508 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21905233 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21558777 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21391780 |
| 116 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20888894 |
| 117 | Legionellosis_Homo sapiens_hsa05134 | 0.20542893 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19739855 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.19736127 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19449897 |
| 121 | Base excision repair_Homo sapiens_hsa03410 | 0.18829815 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.18408314 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.17965537 |
| 124 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.17916202 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.17503058 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.17462735 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16828800 |
| 128 | Melanogenesis_Homo sapiens_hsa04916 | 0.15902202 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15801061 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.15254368 |
| 131 | Circadian entrainment_Homo sapiens_hsa04713 | 0.14023253 |
| 132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.13401899 |
| 133 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.12606272 |
| 134 | Adherens junction_Homo sapiens_hsa04520 | 0.12424472 |
| 135 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12114274 |
| 136 | Histidine metabolism_Homo sapiens_hsa00340 | 0.11347946 |
| 137 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10920560 |
| 138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.09945977 |
| 139 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08912530 |
| 140 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.08881393 |

